Basic Information
| LncRNA/CircRNA Name | LINC00152 |
| Synonyms | CYTOR, C2orf59, LINC00152, NCRNA00152 |
| Region | GRCh38_2:87454781-87636740 |
| Ensemble | ENSG00000222041 |
| Refseq | NR_024204 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | tongue squamous cell carcinoma |
| ICD-0-3 | C02 |
| Methods | qPCR, Western blot, Luciferase reporter assay etc |
| Sample | TSCC tissues,cell lines(SCC-9 and CAL-27) |
| Expression Pattern | up-regulated |
| Function Description | LINC00152 expression is significantly upregulated in TSCC tissues.LINC00152 promotes TSCC cell proliferation and cell cycle progression, and inhibits apoptosis |
| Pubmed ID | 32194700 |
| Year | 2020 |
| Title | Long Non-Coding RNA LINC00152 Acts as a Sponge of miRNA-193b-3p to Promote Tongue Squamous Cell Carcinoma Progression |
External Links
| Links for LINC00152 | GenBank HGNC NONCODE |
| Links for tongue squamous cell carcinoma | OMIM COSMIC |